These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 2818711)
21. Trimethoprim-sulfamethoxazole for bacterial meningitis. Levitz RE; Quintiliani R Ann Intern Med; 1984 Jun; 100(6):881-90. PubMed ID: 6372565 [TBL] [Abstract][Full Text] [Related]
22. The changing patterns of Campylobacter jejuni/coli in Lagos, Nigeria after ten years. Coker AO; Adefeso AO East Afr Med J; 1994 Jul; 71(7):437-40. PubMed ID: 7828496 [TBL] [Abstract][Full Text] [Related]
24. Emergence of multidrug resistance in Campylobacter jejuni isolates from three patients infected with human immunodeficiency virus. Tee W; Mijch A; Wright E; Yung A Clin Infect Dis; 1995 Sep; 21(3):634-8. PubMed ID: 8527556 [TBL] [Abstract][Full Text] [Related]
25. Pattern of antibiotic susceptibility in Campylobacter jejuni isolates of human and poultry origin. Senok A; Yousif A; Mazi W; Sharaf E; Bindayna K; Elnima el-A; Botta G Jpn J Infect Dis; 2007 Feb; 60(1):1-4. PubMed ID: 17314416 [TBL] [Abstract][Full Text] [Related]
26. Trimethoprim-sulfamethoxazole: an assessment of more than 12 years of use. Salter AJ Rev Infect Dis; 1982; 4(2):196-236. PubMed ID: 7051224 [No Abstract] [Full Text] [Related]
28. Emergence of highly trimethoprim-sulfamethoxazole-resistant Shigella in a native American population: an epidemiologic study. Griffin PM; Tauxe RV; Redd SC; Puhr ND; Hargrett-Bean N; Blake PA Am J Epidemiol; 1989 May; 129(5):1042-51. PubMed ID: 2650535 [TBL] [Abstract][Full Text] [Related]
29. In vivo v in vitro susceptibility of enterococcus to trimethoprim-sulfamethoxazole. A pitfall. Goodhart GL JAMA; 1984 Nov; 252(19):2748-9. PubMed ID: 6333522 [TBL] [Abstract][Full Text] [Related]
30. Sulphonamides and trimethoprim. Reeves D Lancet; 1982 Aug; 2(8294):370-3. PubMed ID: 6124767 [No Abstract] [Full Text] [Related]
31. Campylobacter enteritis in Denver. Blaser MJ; Reller LB; Luechtefeld NW; Wang WL West J Med; 1982 Apr; 136(4):287-90. PubMed ID: 7090379 [TBL] [Abstract][Full Text] [Related]
32. Myocarditis in a patient with Campylobacter infection. Reda E; Mansell C N Z Med J; 2005 Aug; 118(1221):U1634. PubMed ID: 16138172 [No Abstract] [Full Text] [Related]
33. In vitro activity of ciprofloxacin compared to trimethoprim-sulfamethoxazole against Campylobacter spp., Shigella spp. and Enterotoxigenic Escherichia coli causing travellers' diarrhea in Egypt. Mikhail IA; Bourgeois AL; Hyams KC; Podgore JK; Lissner CR; Walz S Scand J Infect Dis; 1987; 19(4):479-81. PubMed ID: 3313681 [TBL] [Abstract][Full Text] [Related]
36. In-vitro and in-vivo studies of trimethoprim-sulphamethoxazole against multiple resistant Staphylococcus aureus. Yeldandi V; Strodtman R; Lentino JR J Antimicrob Chemother; 1988 Dec; 22(6):873-80. PubMed ID: 3266621 [TBL] [Abstract][Full Text] [Related]
37. In vitro susceptibility of Campylobacter jejuni and Campylobacter coli isolated in Austria to erythromycin and ciprofloxacin. Hirschl AM; Wolf D; Berger J; Rotter ML Zentralbl Bakteriol; 1990 Apr; 272(4):443-7. PubMed ID: 2360966 [TBL] [Abstract][Full Text] [Related]